| Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of … L Pinede, J Ninet, P Duhaut, S Chabaud, S Demolombe-Rague, I Durieu, ... Circulation 103 (20), 2453-2460, 2001 | 495 | 2001 |
| Autoimmune and inflammatory manifestations occur frequently in patients with primary immunodeficiencies A Fischer, J Provot, JP Jais, A Alcais, N Mahlaoui, D Adoue, N Aladjidi, ... Journal of Allergy and Clinical Immunology 140 (5), 1388-1393. e8, 2017 | 305 | 2017 |
| Adult-onset still disease: manifestations, treatment, outcome, and prognostic factors in 57 patients M Gerfaud-Valentin, D Maucort-Boulch, A Hot, J Iwaz, J Ninet, I Durieu, ... Medicine 93 (2), 91-99, 2014 | 278 | 2014 |
| The clinical phenotype associated with myositis-specific and associated autoantibodies: a meta-analysis revisiting the so-called antisynthetase syndrome JC Lega, N Fabien, Q Reynaud, I Durieu, S Durupt, M Dutertre, JF Cordier, ... Autoimmunity reviews 13 (9), 883-891, 2014 | 276 | 2014 |
| Neurologic presentation of Whipple disease: report of 12 cases and review of the literature A Gerard, F Sarrot-Reynauld, E Liozon, P Cathebras, G Besson, C Robin, ... Medicine 81 (6), 443-457, 2002 | 216 | 2002 |
| Prognostic value of troponins in sepsis: a meta-analysis F Bessière, S Khenifer, J Dubourg, I Durieu, JC Lega Intensive care medicine 39, 1181-1189, 2013 | 214 | 2013 |
| Rapid improvement after starting elexacaftor–tezacaftor–ivacaftor in patients with cystic fibrosis and advanced pulmonary disease PR Burgel, I Durieu, R Chiron, S Ramel, I Danner-Boucher, A Prevotat, ... American journal of respiratory and critical care medicine 204 (1), 64-73, 2021 | 179 | 2021 |
| Idiopathic inflammatory myopathies and the lung JC Lega, Q Reynaud, A Belot, N Fabien, I Durieu, V Cottin European Respiratory Review 24 (136), 216-238, 2015 | 179 | 2015 |
| Efficacy and safety of rituximab in auto-immune hemolytic anemia: A meta-analysis of 21 studies Q Reynaud, I Durieu, M Dutertre, S Ledochowski, S Durupt, AS Michallet, ... Autoimmunity reviews 14 (4), 304-313, 2015 | 146 | 2015 |
| Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients F Lachenal, F Berger, H Ghesquières, P Biron, A Hot, E Callet-Bauchu, ... Medicine 86 (5), 282-292, 2007 | 144 | 2007 |
| Long-term efficacy and safety of cladribine (2-CdA) in adult patients with mastocytosis S Barete, O Lortholary, G Damaj, I Hirsch, MO Chandesris, C Elie, ... Blood, The Journal of the American Society of Hematology 126 (8), 1009-1016, 2015 | 143 | 2015 |
| Determinants of hydroxychloroquine blood concentration variations in systemic lupus erythematosus M Jallouli, L Galicier, N Zahr, O Aumaitre, C Frances, V Le Guern, F Lioté, ... Arthritis & rheumatology 67 (8), 2176-2184, 2015 | 136 | 2015 |
| Real-life safety and effectiveness of lumacaftor–ivacaftor in patients with cystic fibrosis PR Burgel, A Munck, I Durieu, R Chiron, L Mely, A Prevotat, ... American journal of respiratory and critical care medicine 201 (2), 188-197, 2020 | 125 | 2020 |
| Treatment of idiopathic inflammatory myositis associated interstitial lung disease: a systematic review and meta-analysis T Barba, R Fort, V Cottin, S Provencher, I Durieu, S Jardel, A Hot, ... Autoimmunity reviews 18 (2), 113-122, 2019 | 119 | 2019 |
| Mutations in CECR1 associated with a neutrophil signature in peripheral blood A Belot, E Wassmer, M Twilt, JC Lega, LAH Zeef, A Oojageer, PR Kasher, ... Pediatric Rheumatology 12, 1-7, 2014 | 110 | 2014 |
| Investigators of the “Durée Optimale du Traitement AntiVitamines K”(DOTAVK) Study. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal … L Pinede, J Ninet, P Duhaut, S Chabaud, S Demolombe-Rague, I Durieu, ... Circulation 103 (20), 2453-2460, 2001 | 93 | 2001 |
| Sclerosing cholangitis in adults with cystic fibrosis: a magnetic resonance cholangiographic prospective study I Durieu, O Pellet, L Simonot, S Durupt, G Bellon, DV Durand Journal of hepatology 30 (6), 1052-1056, 1999 | 89 | 1999 |
| Characteristics, outcome, and response to therapy of multirefractory chronic immune thrombocytopenia M Mahévas, M Gerfaud-Valentin, G Moulis, L Terriou, S Audia, S Guenin, ... Blood, The Journal of the American Society of Hematology 128 (12), 1625-1630, 2016 | 87 | 2016 |
| Cystic fibrosis and pregnancy. Report from French data (1980–1999) D Gillet, M de Braekeleer, G Bellis, I Durieu, ... BJOG: an international journal of obstetrics and gynaecology 109 (8), 912-918, 2002 | 86 | 2002 |
| Subepithelial fibrosis and degradation of the bronchial extracellular matrix in cystic fibrosis I Durieu, S Peyrol, D Gindre, G Bellon, DV Durand, Y Pacheco American journal of respiratory and critical care medicine 158 (2), 580-588, 1998 | 86 | 1998 |
